| SUNY/Stony Brook, PhD | |
| Biochemistry and Molecular Biology |
Dr. Jack Roos has 12 years of research and discovery experience, with more than five of those in biotechnology. Prior to joining CalciMedica, Dr. Roos was Principal Scientist at TorreyPines Therapeutics. Dr. Roos, along with Dr. Stauderman, co-authored the discovery of STIM1, which has an essential role in CRAC channel activity and which is important for immune cell activation.